Solventum Corporation (SOLV)
61.34 x 1 77.97 x 1
Pre-market by (Cboe BZX)
63.01 -2.31 (-3.54%) 04/08/25 [NYSE]
61.34 x 1 77.97 x 1
Pre-market 60.00 -3.01 (-4.78%) 05:42 ET
for Tue, Apr 8th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | |
Cash Flows From Operating Activities | |||
Net Income | 479,000 | 1,346,000 | 1,343,000 |
Depreciation Amortization | 555,000 | 561,000 | 578,000 |
Income taxes - deferred | -155,000 | -142,000 | -141,000 |
Accounts receivable | 43,000 | -129,000 | -32,000 |
Accounts payable and accrued liabilities | 266,000 | 105,000 | 25,000 |
Other Working Capital | 160,000 | 126,000 | -202,000 |
Other Operating Activity | -163,000 | 48,000 | 108,000 |
Operating Cash Flow | $1,185,000 | $1,915,000 | $1,679,000 |
Cash Flows From Investing Activities | |||
PPE Investments | -380,000 | -290,000 | -251,000 |
Net Acquisitions | N/A | 60,000 | N/A |
Other Investing Activity | 0 | 0 | -2,000 |
Investing Cash Flow | $-380,000 | $-230,000 | $-253,000 |
Cash Flows From Financing Activities | |||
Debt Issued | 8,303,000 | N/A | N/A |
Debt Repayment | -300,000 | N/A | N/A |
Other Financing Activity | -8,243,000 | -1,552,000 | -1,460,000 |
Financing Cash Flow | $-240,000 | $-1,552,000 | $-1,460,000 |
Exchange Rate Effect | 3,000 | N/A | 4,000 |
Beginning Cash Position | 194,000 | 61,000 | 91,000 |
End Cash Position | 762,000 | 194,000 | 61,000 |
Net Cash Flow | $568,000 | $133,000 | $-30,000 |
Free Cash Flow | |||
Operating Cash Flow | 1,185,000 | 1,915,000 | 1,679,000 |
Capital Expenditure | -380,000 | -290,000 | -251,000 |
Free Cash Flow | 805,000 | 1,625,000 | 1,428,000 |